查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1252569

2023-2032 年全球除颤器市场 - 按产品、最终用途、全球预测

Defibrillators Market - By Product, End-use & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 320 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于新兴国家/地区对可穿戴除颤器的偏好和采用率不断上升，预计除颤器的全球市场将从 2023 年到 2032 年实现强劲增长。

植入式心律转復除颤器 (ICD) 技术的众多创新有望改善除颤器的性能、功能和临床结果。 此外，对除颤器的需求显着增加，因为临床试验表明佩戴除颤器可以提高心臟骤停高风险人群的生存率。

由于手术设备的改进和各种产品创新，除颤器植入术已成为门诊手术。 例如，2020 年 7 月，雅培（Abbott）实验室的 Gallant 产品线获得了 FDA 的批准，该产品线是一系列开创性的联网起搏器和除颤器植入物。 这一监管批准使该公司能够加强其创新技术管道，并有助于增加患者、护理提供者和医生之间的互动。

除颤器市场按产品、最终用途和地区划分。

按产品划分，体外除颤器细分市场预计将在预测期内占据重要的市场份额。 预计这种增长将受到越来越多地采用这些设备和技术改进的推动，这些技术改进使它们易于使用和自动化。 院外心臟骤停 (OHCA) 是发病率和死亡率的重要驱动因素，增加了消费者对设备的兴趣。

就最终用途而言，估计门诊手术中心市场在分析期间将显着增长。 ICD 植入在门诊手术诊所中的应用显着增加。 在这样的医疗环境下，ICD 报销政策的加强有望进一步增加该分部的收入。

按地区划分，2022年北美除颤器市场份额将超过37%。 这是由于该地区用于研发创新技术的私人研究资金有所增加。 该地区主要市场进入者的主导地位、慢性心脏病患病率上升、政府支持措施和有利的报销制度都有助于其市场主导地位。 此外，完善的医疗基础设施和专业的医务人员也是推动北美除颤器市场增长的因素。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章除颤器行业洞察

  • 行业情况
  • 影响行业的因素
    • 司机
      • 心脏病患病率上升
      • 技术进步和创新设备的引进
      • 提高社会认可度
      • 对可穿戴除颤器的需求不断扩大
    • 行业潜在的风险和挑战
      • 设备价格高
      • 产品召回
  • 增长分析
    • 按产品分类
    • 按最终用途
  • COVID-19 影响分析
  • 2022 年按地区划分的价格分析
  • 监管状况
    • 美国
    • 欧洲
  • 退款场景
    • 植入式心律转復除颤器 (ICD)
    • 自动体外除颤器 (AED)
  • 技术概况
  • 管道产品
  • 显示风景
    • 植入式心律转復除颤器 (ICD)
    • 可穿戴式体外除颤器 (WCD)
  • 启动场景
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2021 年

  • 介绍
  • 2021 年公司矩阵分析
  • 2021 年版全球公司份额分析
  • 战略仪表板，2021 年

第 5 章除颤器市场：按产品分类

  • 主要产品趋势
  • 植入式心律转復除颤器 (ICD)
    • 皮下植入式除颤器
    • 经静脉植入式心律转復除颤器
      • 单腔 ICD
      • 双腔 ICD
  • 体外心臟復律除颤器
    • 手动体外除颤器
    • 自动体外除颤器
      • 半自动体外除颤器
      • 全自动体外除颤器
    • 可穿戴式体外除颤器

第 6 章除颤器市场：按最终用途分类

  • 主要的最终用户趋势
  • 医院
  • 门诊手术中心
  • 其他

第 7 章除颤器市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 波兰
    • 荷兰
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 印度尼西亚
    • 泰国
    • 马来西亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥伦比亚
    • 秘鲁
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 以色列
    • 伊朗
    • 土耳其人

第八章公司简介

  • Abbott Laboratories, Inc.
  • AMI Italia
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CU Medical Systems Co. Ltd
  • Koninkilijke Philips N.V.
  • Medtronic plc
  • Meditech Equipment Co., Ltd（Meditech Group）
  • MicroPort Scientific Corporation
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • BPL Medical Technologies Pvt Ltd
  • Schiller AG
  • Stryker Corporation
  • ZOLL Medical Corporation（Asahi Kasei Group）
简介目录
Product Code: 5495

Global Defibrillators Market is set to witness robust growth between 2023 to 2032, owing to the surging preference for wearable cardioverter defibrillators and their adoption in several emerging nations.

The performance of the device, the functions it offers, as well as the clinical results, are all projected to improve as a result of numerous technological innovations in implantable cardioverter defibrillator (ICD) technology. Moreover, the demand for defibrillators has significantly increased due to clinical trials demonstrating improved survival rates in people at greater risk of cardiac arrest who get defibrillators.

Defibrillator implantation has become an outpatient operation given the improvements in surgical equipment and different product innovations. For instance, in July 2020, Abbott Laboratories received an FDA approval for its Gallant product line, a breakthrough series of connected pacemakers as well as defibrillator implants. The regulatory approval enabled the company to strengthen its pipeline of innovative technologies, which also helped increase interaction between patients, care providers, and physicians.

The defibrillator market has been divided in terms of product, end-use, and region.

Based on product, the external cardioverter defibrillator segment is expected to garner a sizable market share through the forecast period. The growth is expected to be accelerated by the growing adoption of these devices, and technical improvements that are enabling easy use & automation. Out-of-hospital cardiac arrest (OHCA) is one of the important factors that contribute to the morbidity and mortality, as well as fueling consumer interest in the device.

With respect to end-use, the ambulatory surgical centers market is estimated to grow significantly over the analysis timeframe. ICD implantation procedures are seeing a noticeable increase in the ambulatory surgery clinics. The segment revenue will be further boosted by the increasing reimbursement policies for ICDs in these healthcare settings.

From the regional perspective, the North America defibrillator market held more than 37% business share in 2022 credited to the rise in private research funding for the research and development of innovative technologies across the region. The predominance of major market players, the rising rate of chronic cardiac illnesses, supportive government measures, and a favorable reimbursement system, all contribute to the region's dominant market position. Moreover, the availability of well-equipped healthcare infrastructure and professional medical staff is also set to foster North America defibrillators market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Defibrillators industry 360 degree synopsis, 2018-2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Defibrillators Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cardiac diseases
      • 3.2.1.2 Technological advancements and introduction of innovative devices
      • 3.2.1.3 Increasing public awareness
      • 3.2.1.4 Increasing demand for wearable cardioverter defibrillators
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Product recalls
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By end use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Pricing analysis, by region, 2022
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 Latin America
    • 3.5.5 MEA
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Reimbursement scenario
    • 3.7.1 Implantable cardioverter defibrillators (ICDs)
    • 3.7.2 Automatic External Defibrillators (AEDs)
  • 3.8 Technology landscape
  • 3.9 Pipeline products
  • 3.10 Indication landscape
    • 3.10.1 Implantable cardioverter defibrillators (ICDs)
    • 3.10.2 Wearable external cardioverter defibrillators (WCDs)
  • 3.11 Startup scenario
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Global company market share analysis, 2021
  • 4.4 Strategy dashboard, 2021

Chapter 5 Defibrillators Market, By Product

  • 5.1 Key product trends
  • 5.2 Implantable Cardioverter Defibrillator (ICDs)
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.2.3 Subcutaneous implantable cardioverter defibrillator
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.2.4 Transvenous implantable cardioverter defibrillator
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.2.4.3 Single-chamber ICDs
        • 5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.2.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.2.4.4 Dual-chamber ICDs
        • 5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.2.4.4.2 Market estimates and forecast, 2018 - 2032 (Units)
  • 5.3 External cardioverter defibrillator
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.3 Manual external defibrillator
        • 5.3.3.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.3.1.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.4 Automated external defibrillator
        • 5.3.4.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.1.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.3.4.2 Semi-automated external defibrillator
        • 5.3.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.2.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.3.4.3 Fully automated external defibrillator
        • 5.3.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.5 Wearable external cardioverter defibrillator
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.5.2 Market estimates and forecast, 2018 - 2032 (Units)

Chapter 6 Defibrillators Market, By End-use

  • 6.1 Key end-use trends
  • 6.2 Hospitals
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Ambulatory surgical centers
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Others
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Defibrillators Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Poland
    • 7.3.7 The Netherlands
    • 7.3.8 Sweden
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Thailand
    • 7.4.8 Malaysia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Chile
    • 7.5.5 Columbia
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Israel
    • 7.6.5 Iran
    • 7.6.6 Turkey

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories, Inc.
  • 8.2 AMI Italia
  • 8.3 BIOTRONIK SE & Co. KG
  • 8.4 Boston Scientific Corporation
  • 8.5 CU Medical Systems Co. Ltd
  • 8.6 Koninkilijke Philips N.V.
  • 8.7 Medtronic plc
  • 8.8 Meditech Equipment Co., Ltd (Meditech Group)
  • 8.9 MicroPort Scientific Corporation
  • 8.10 Mindray Medical International Limited
  • 8.11 Nihon Kohden Corporation
  • 8.12 BPL Medical Technologies Pvt Ltd
  • 8.13 Schiller AG
  • 8.14 Stryker Corporation
  • 8.15 ZOLL Medical Corporation (Asahi Kasei Group)